{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:51:44Z","timestamp":1770137504207,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Young Scientists (B)","award":["17K16267"],"award-info":[{"award-number":["17K16267"]}]},{"name":"Grant-in-Aid for Scientific Research (B)","award":["16H05348"],"award-info":[{"award-number":["16H05348"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T03:39:24Z","timestamp":1544672364000},"page":"612-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Takashi","family":"Kimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.12.002_b0005","series-title":"Influenza (seasonal) fact sheet","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2018.12.002_b0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0300985816681411","article-title":"H3N2 Canine influenza virus infection in a dog","volume":"54","author":"Watson","year":"2017","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/cid\/cix668","article-title":"Outbreak of influenza A(H7N2) among cats in an animal shelter with cat-to-human transmission-New York city, 2016","volume":"65","author":"Lee","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.12.002_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature03974","article-title":"Avian flu: H5N1 virus outbreak in migratory waterfowl","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.12.002_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tim.2008.01.008","article-title":"Evolving complexities of influenza virus and its receptors","volume":"16","author":"Nicholls","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/440435a","article-title":"Avian flu: Influenza virus receptors in the human airway","volume":"440","author":"Shinya","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.12.002_b0040","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/JVI.00148-11","article-title":"Systemic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation","volume":"85","author":"Shinya","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2018.12.002_b0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7883\/yoken.JJID.2004.236","article-title":"Defense mechanisms against influenza virus infection in the respiratory tract mucosa","volume":"57","author":"Tamura","year":"2004","journal-title":"Jpn J Infec Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0055","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.176.2.1122","article-title":"Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen","volume":"176","author":"Mizuno","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0060","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/irv.12124","article-title":"Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses","volume":"7","author":"Kimoto","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.12.002_b0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.12.002_b0070","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1016\/j.vaccine.2009.07.024","article-title":"Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigs","volume":"27","author":"Nishino","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.002_b0075","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.vaccine.2011.05.090","article-title":"Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity","volume":"29","author":"Mizuno","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.002_b0080","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.vaccine.2016.02.061","article-title":"Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys","volume":"34","author":"Mizuno","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.002_b0085","article-title":"Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.12.002_b0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1164\/ajrccm\/136.2.426","article-title":"Metabolism and turnover of lung surfactant","volume":"136","author":"Wright","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0095","first-page":"541","article-title":"Fetal lung lamellar bodies in human amniotic fluid","volume":"117","author":"Hook","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1203\/01.pdr.0000228329.90502.3a","article-title":"Micelles of pulmonary surfactant in human amniotic fluid at term","volume":"60","author":"Nishijima","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2018.12.002_b0105","doi-asserted-by":"crossref","first-page":"L208","DOI":"10.1152\/ajplung.00081.2011","article-title":"Interactions among pulmonary surfactant, vernix caseosa, and intestinal enterocytes: intra-amniotic administration of fluorescently liposomes to pregnant rabbits","volume":"303","author":"Nishijima","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.8.3.652-657.2001","article-title":"Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization","volume":"8","author":"Barackman","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/175.2.352","article-title":"Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine","volume":"175","author":"Katz","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0120","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"Mann","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.002_b0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/CVI.00552-12","article-title":"An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models","volume":"20","author":"Scallan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.002_b0135","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jmv.23768","article-title":"Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection","volume":"86","author":"Liu","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1746-6148-8-105","article-title":"Enhancement of Th1-biased protective immunity against avian influenza H9N2 virus via oral co-administration of attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-alpha and interleukin-18 along with an inactivated vaccine","volume":"8","author":"Rahman","year":"2012","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2018.12.002_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129276","article-title":"Oral delivery of a novel attenuated salmonella vaccine expressing influenza A virus proteins protects mice against H5N1 and H1N1 viral infection","volume":"10","author":"Pei","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.12.002_b0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00915547","article-title":"The common mucosal immune system and current strategies for induction of immune responses in external secretions","volume":"7","author":"Mestecky","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-3603-8_16","article-title":"Macrophage isolation from the mouse small and large intestine","volume":"1422","author":"Harusato","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0160","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.micinf.2010.04.013","article-title":"Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus","volume":"12","author":"Takahashi","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.12.002_b0165","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ajpath.2015.02.024","article-title":"Intestinal antigen-presenting cells: key regulators of immune homeostasis and inflammation","volume":"185","author":"Flannigan","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0170","first-page":"L1266","article-title":"Macropgage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs","volume":"280","author":"Gurel","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fimmu.2011.00025","article-title":"The role of CD103(+) dendritic cells in the intestinal mucosal immune system","volume":"2","author":"Ruane","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0180","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.12.002_b0185","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1073\/pnas.0812681106","article-title":"A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota","volume":"106","author":"Cong","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.12.002_b0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mi.2017.105","article-title":"CD103(+)CD11b(+) mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin","volume":"11","author":"Flores-Langarica","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0195","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.002_b0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2016.02.014","article-title":"Mucosal vaccine delivery: current state and a pediatric perspective","volume":"240","author":"Shakya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2018.12.002_b0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ni.2552","article-title":"Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses","volume":"14","author":"Hirota","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0215","doi-asserted-by":"crossref","first-page":"e02111","DOI":"10.1128\/JVI.02111-16","article-title":"CpG in combination with an inhibitor of Notch signaling suppresses formalin-inactivated respiratory syncytial virus-enhanced airway hyperresponsiveness and inflammation by inhibiting Th17 memory responses and promoting tissue-resident memory cells in lungs","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.12.002_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003875","article-title":"Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection","volume":"10","author":"Maroof","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.12.002_b0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","article-title":"Mucosal vaccine adjuvants update","volume":"1","author":"Rhee","year":"2012","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2018.12.002_b0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0168-3659(96)01459-9","article-title":"Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability","volume":"42","author":"Chen","year":"1996","journal-title":"J Controlled Release"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18316475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18316475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:32Z","timestamp":1759400972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18316475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18316475"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}